All‐cause mortality · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in mortality compared with UFH prophylaxis (moderate certainty).
1 finding from 1 review
Postoperative transfusion Median · People with cancer with perioperative thromboprophylaxis
1 finding from 1 review
Intraoperative blood loss (mL) · People with cancer with perioperative thromboprophylaxis
1 finding from 1 review
Postoperative drain volume · People with cancer with perioperative thromboprophylaxis
1 finding from 1 review
Thrombocytopenia · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in thrombocytopenia compared with UFH prophylaxis (moderate certainty).
1 finding from 1 review
Mortality ‐ not reported · People with cancer with perioperative thromboprophylaxis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total VTE · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in any VTE compared with fondaparinux prophylaxis (low certainty).
1 finding from 1 review
Major bleeding · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in major Bleeding compared with fondaparinux prophylaxis (low certainty).
1 finding from 1 review
Minor bleeding · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in minor Bleeding compared with fondaparinux prophylaxis (low certainty).
1 finding from 1 review
Thrombocytopenia · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in thrombocytopenia compared with fondaparinux prophylaxis (low certainty).
1 finding from 1 review
Pulmonary embolism · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in any Pulmonary embolism compared with fondaparinux prophylaxis (low certainty).
1 finding from 1 review
Any PE · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in any PE compared with UFH prophylaxis (moderate certainty).
1 finding from 1 review
Postoperative drain volume · People with cancer with perioperative thromboprophylaxis
1 finding from 1 review
Symptomatic DVT · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in symptomatic DVT compared with UFH prophylaxis (moderate certainty).
1 finding from 1 review
Symptomatic DVT measured as asymptomatic DVT · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in symptomatic DVT measured as asymptomatic DVT compared with UFH prophylaxis (low certainty).
1 finding from 1 review
Major bleeding · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in major bleeding compared with UFH prophylaxis (moderate certainty).
1 finding from 1 review
Minor bleeding · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in minor bleeding compared with UFH prophylaxis (moderate certainty).
1 finding from 1 review
Wound hematoma · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis probably leads to lower wound hematoma compared with UFH prophylaxis (moderate certainty).
1 finding from 1 review
Adverse events (Re‐operation for bleeding (reoperation for major bleeding within 30 days (yes/no))) · People with cancer with perioperative thromboprophylaxis
LMWH prophylaxis showed no clear difference in reoperation for bleeding compared with UFH prophylaxis (moderate certainty).
1 finding from 1 review
Intraoperative transfusion · People with cancer with perioperative thromboprophylaxis
1 finding from 1 review